Centrillion Biosciences

Centrillion Biosciences is a biomolecular technology company based in Palo Alto, California, founded in 2009. The firm develops high-density DNA chips and the wafer-scale manufacturing systems used to produce them. Its stated aim is to decode genomes, cells and tissues with precision, measuring molecular signals for work in spatial biology, genomics and AI-powered biological analysis.

The company's technical work spans several domains: DNA chip technology, photolithographic synthesis, light-directed synthetic biology, wafer-scale manufacturing and viral genome sequencing. Its light-directed synthetic biology platform combines photolithographic synthesis with programmable probe content and advanced manufacturing techniques to generate biological data at scale. Its high-density DNA chips are applied across life sciences research, pharmaceutical and academic research, drug discovery, diagnostics and personalised medicine.

During the COVID-19 pandemic the company developed sequencing chips that provided faster and more accurate methods of viral genome sequencing from clinical samples, reporting over 99.9% accuracy. Employees and candidates work in an organisation oriented toward technical capability and the demonstration of platform performance in applied settings.